Regulation of survivin expression by IGF-1/mTOR signaling
Open Access
- 30 October 2006
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (19) , 2678-2684
Abstract
Survivin is a dual regulator of cell proliferation and cell viability overexpressed in most human tumors. Although strategies to lower survivin levels have been pursued for rational cancer therapy, the molecular circuitries controlling survivin expression in tumors have not been completely elucidated. Here, we show that stimulation with insulin-like growth factor-1 (IGF-1) results in increased survivin expression in prostate cancer cells. This response is independent of de novo gene transcription, changes in mRNA expression or modifications of survivin protein stability. Instead, IGF-1 induced persistence and translation of a pool of survivin mRNA, in a reaction abolished by the mTOR (mammalian target of rapamycin) inhibitor, rapamycin. Forced expression of the mTOR target p70S6K1 reproduced the increase in survivin expression in prostate cancer cells, whereas acute ablation of endogenous p70S6K1 by small interfering RNA downregulated survivin levels. Rapamycin, alone or in combination with suboptimal concentrations of taxol reduced survivin protein levels, and decreased viability of prostate cancer cells. Therefore, IGF-1/mTOR signaling elevates survivin in prostate cancer cells via rapid changes in mRNA translation. Antagonists of this pathway may be beneficial to lower an antiapoptotic threshold maintained by survivin in prostate cancer.Keywords
This publication has 38 references indexed in Scilit:
- Targeted therapy by disablingcrossroadsignaling networks: the survivin paradigmMolecular Cancer Therapeutics, 2006
- The survival kinases Akt and Pim as potential pharmacological targetsJournal of Clinical Investigation, 2005
- Mitochondrial survivin inhibits apoptosis and promotes tumorigenesisJournal of Clinical Investigation, 2004
- Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosisOncogene, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivinBlood, 2003
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002
- Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription FactorCell, 1999
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 1997